Gender specific effects of ethanol in mice, lacking CCK2 receptors

Behavioural Brain Research

Volumn 175, Issue 1, 2006, Pages 149-156

  Abramov, Urho ^a   Raud, Sirli ^a   Innos, Jürgen ^a   Kõks, Sulev ^a   Matsui, Toshimitsu ^b   Vasar, Eero ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anxiety; CCK2 receptor deficient mice; Ethanol; Ethanol intake; Locomotor activity; Sensitivity

Indexed keywords

ALCOHOL; CHOLECYSTOKININ B RECEPTOR;

ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; GABAERGIC SYSTEM; GENDER; GENETIC VARIABILITY; KNOCKOUT MOUSE; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; RIGHTING REFLEX; SEDATION; SENSITIVITY ANALYSIS; SEX DIFFERENCE; TASTE PREFERENCE; TRANQUILIZING ACTIVITY; WILD TYPE;

ALCOHOL DRINKING; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; FEMALE; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; RECEPTOR, CHOLECYSTOKININ B; REFLEX; ROTAROD PERFORMANCE TEST; SEX CHARACTERISTICS; TASTE; TIME FACTORS;

EID: 33750628420     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2006.08.015     Document Type: Article

References (43)

1. Abramov U., Raud S., Kõks S., Innos J., Kurrikoff K., Matsui T., et al. Targeted mutation of CCK(2) receptor gene antagonises behavioural changes induced by social isolation in female, but not in male mice. Behav Brain Res 155 (2004) 1-11
2. Belknap J.K., Crabbe J.C., and Young E.R. Voluntary consumption of ethanol in 15 inbred mouse strains. Psychopharmacology 112 (1993) 503-510
3. Blanchard B.A., Steindorf S., Wang S., and Glick S.D. Sex differences in ethanol-induced dopamine release in nucleus accumbens and in ethanol consumption in rats. Alcohol Clin Exp Res 17 (1993) 968-973
4. Budygin E.A., Phillips P.E., Robinson D.L., Kennedy A.P., Gainetdinov R.R., and Wightman R.M. Effect of acute ethanol on striatal dopamine neurotransmission in ambulatory rats. J Pharmacol Exp Ther 297 (2001) 27-34
5. Costall B., Domeney A.M., Hughes J., Kelly M.E., Naylor R.J., and Woodruff G.N. Anxiolytic effects of CCK-B antagonists. Neuropeptides 19 (1991) 65-73
6. Crawley J.N. Interactions between cholecystokinin and other neurotransmitter systems. In: Bradwejn J., and Vasar E. (Eds). Cholecystokinin and anxiety: from neuron to behaviour (1995), Springer-Verlag/R.G. Landes Company, Austin 101-126
7. Crawley J.N., and Corwin R.L. Biological actions of cholecystokinin. Peptides 15 (1994) 731-755
8. Crespi F. The role of cholecystokinin (CCK), CCK-A or CCK-B receptor antagonists in the spontaneous preference for drugs of abuse (alcohol or cocaine) in naive rats. Meth Find Exp Clin Pharmacol 20 (1998) 679-697
9. Crespi F., Corsi M., England T., Ratti E., Trist D.G., and Gaviraghi G. Spontaneous preference for ethanol in naive rats is influenced by cholecystokinin A receptor antagonism. Alcohol 14 (1997) 327-332
10. Criswell H.E., and Breese G.R. A conceptualisation of integrated actions of ethanol contributing to its GABAmimetic profile: a commentary. Neuropsychopharmacology 30 (2005) 1407-1425
11. Croft A.P., Brooks S.P., Cole J., and Little H.J. Social defeat increases alcohol preference of C57BL/10 strain mice; effect prevented by a CCKB antagonist. Psychopharmacology (Berl) 183 (2005) 163-170
12. Daugé V., Beslot F., Matsui T., and Roques B.P. Mutant mice lacking the cholecystokinin2 receptor show a dopamine-dependent hyperactivity and a behavioural sensitization to morphine. Neurosci Lett 306 (2001) 41-44
13. Daugé V., and Lena I. CCK in anxiety and cognitive processes. Neurosci Biobehav Rev 22 (1998) 815-825
14. Davies M. The role of GABAA receptors in mediating the effects of alcohol in the central nervous system. J Psychiat Neurosci 28 (2003) 263-274
15. DiBattista D., McKenzie T.L.B., and Hollis-Walker L. Cholecystokinin reduces ethanol consumption in golden hamsters. Alcohol 29 (2003) 173-181
16. Geary N., Wolfe A., Polidori C., Policani F., and Massi M. Exogeneous and endogenous CCK inhibit ethanol ingestion in Sardinian alcohol-preferring rats. Peptides 25 (2004) 1185-1194
17. Handley S.L., and Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn-Schmiedebergs Arch Pharmacol 327 (1984) 1-5
18. Harro J., Wahlstrom G., and Oreland L. Cholecystokinin receptor binding after long-term ethanol treatment in rats. Alcohol Alcohol 29 (1994) 575-581
19. Kõks S., Volke V., Veraksits A., Rünkorg K., Sillat T., Abramov U., et al. Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system. Psychopharmacology (Berl) 58 (2001) 198-204
20. Kulkosky P.J. Neuropeptidergic control of ethanol intake. J Toxicol Toxin Rev 15 (1996) 341-351
21. Lancaster F.E., and Spiegel K.S. Sex differences in patterns of drinking. Alcohol 9 (1992) 415-420
22. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 92 (1987) 180-185
23. Little H.J., O'Callaghan M.J., Butterworth A.R., Wilson J., Cole J., and Watson W.P. Low alcohol preference among the "high alcohol preference" C57 strain of mice; preference increased by saline injections. Psychopharmacology (Berl) 147 (1999) 182-189
24. Löw K., Crestani F., Keist R., Benke D., Brünig I., Benson J.A., et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290 (2000) 131-134
25. Meliska C.J., Bartke A., McGlacken G., and Jensen R.A. Ethanol, nicotine, amphetamine, and aspartame consumption and preferences in C57BL/6 and DBA/2 mice. Pharmacol Biochem Behav 50 (1995) 619-626
26. Middaugh L.D., Kelley B.M., Bandy A.L., and McGroarty K.K. Ethanol consumption by C57BL/6 mice: influence of gender and procedural variables. Alcohol 17 (1999) 175-183
27. Miyasaka K., Hosoya H., Takano S., Ohta M., Sekime A., Kanai S., et al. Differences in ethanol ingestion between cholecystokinin-A receptor deficient and -B receptor deficient mice. Alcohol Alcohol 40 (2005) 176-180
28. Möhler H., Fritschy J.M., and Rudolph U. A new benzodiazepine pharmacology. Pharmacol Exp Ther 300 (2002) 2-8
29. Nagata A., Ito M., Iwata N., Kuno J., Takano H., Minowa O., et al. G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo. Proc Natl Acad Sci USA 93 (1996) 11825-11830
30. Noble F., Wank S.A., Crawley J.N., Bradwejn J., Seroogy K.B., Hamon M., et al. International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol Rev 51 (1999) 745-781
31. Pierce R.C., and Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev 25 (1997) 192-216
32. 2 receptor in mice results in an upregulation of the endogenous opioid system. J Neurosci 22 (2002) 2005-2011
33. Raud S., Innos J., Abramov U., Reimets A., Kõks S., Soosaar A., et al. Targeted invalidation of CCK(2) receptor gene induces anxiolytic-like action in light-dark exploration, but not in fear conditioning test. Psychopharmacology (Berl) 181 (2005) 347-357
34. 2 receptor gene modifies the behavioural effects of diazepam in female mice. Psychopharmacology (Berl) 168 (2003) 417-425
35. Rehfeld J.F., and Nielsen F.C. Molecular forms and regional distribution of cholecystokinin in the central nervous system. In: Bradwejn J., and Vasar E. (Eds). Cholecystokinin and anxiety: from neuron to behaviour (1995), Springer-Verlag/R.G. Landes Company, Austin 33-56
36. Rotzinger S., and Vaccarino F.J. Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models. J Psychiat Neurosci 28 (2003) 171-181
37. 2 receptor deficient mice. Neurosci Lett 406 (2006) 17-22
38. 2 receptor-deficient mice. Behav Brain Res 144 (2003) 125-135
39. Toth P., Shaw C., Perlanski E., and Grupp L.A. Cholecystokinin octapeptide reduces ethanol intake in food- and water-sated rats. Pharmacol Biochem Behav 35 (1990) 493-495
40. 2 receptors. Psychopharmacology (Berl) 166 (2003) 168-175
41. Weatherford S.C., Figlewicz D.P., Park C.R., and Woods S.C. Chronic alcohol consumption increases sensitivity to the anorexic effect of cholecystokinin. Am J Physiol 265 (1993) 211-215
42. Wilson J., and Little H.J. CCK(B) antagonists protect against some aspects of the ethanol withdrawal syndrome. Pharmacol Biochem Behav 59 (1998) 967-973
43. Wilson J., Watson W.P., and Little H.J. CCK(B) antagonists protect against anxiety-related behaviour produced by ethanol withdrawal, measured using the elevated plus-maze. Psychopharmacology (Berl) 137 (1998) 120-131